Palisade Bio, Inc. ( PALI) - Stock Earnings
PALI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.9 million USD | — USD |
| 2025Q4 | -8.9 million USD | — USD |
| 2026Q1 | -9.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PALI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.3 million USD | 250000 USD |
| 2024 | -14.4 million USD | — USD |
| 2025 | -16.8 million USD | — USD |
| 2026 Est. | — | — |
PALI
Price: $1.93
52 week price:
Earnings Per Share: 0.12 USD
P/E Ratio: 15.25
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 369800
Market Capitalization: 335.0 million